Skip to main navigation

About Us

Our Company

Overview Management Team Board of Directors Scientific Advisory Board Partners & Collaborations

Contact

Our Pipeline

Pipeline

Overview Azenosertib ZN-d5 BCL-xL Degrader

Clinical Trials

Our Approach

Integrated Discovery Engine

Our advanced approach to efficiently identifying and developing novel oncology therapies.

Supporting Publications

Investors & Media

Investor Home

News & Events

Press Releases Events & Presentations

Stock Information

Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage

Financials & Filings

SEC Filings

Corporate Governance

Documents & Charters Management Team Board of Directors Scientific Advisory Committee Committee Composition

Investor Resources

Investor FAQs Investor Contact Email Alerts

Careers

Working at Zentalis

Be part of a vibrant team committed to our common goal: to better the lives of patients impacted by cancer.

Job Opportunities

Investors & Media

Events & Presentations

Investor Relations Menu

Investor Home

News & Events

Press Releases Events & Presentations

Stock Information

Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage

Financials & Filings

SEC Filings

Corporate Governance

Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition

Investor Resources

Investor FAQs Investor Contact Email Alerts

Contact

Elizabeth Pingpank Hickin
Vice President, Investor Relations
ehickin@zentalis.com

Corporate Presentation

Corporate Presentation – June 2024

Upcoming Events

There are no upcoming events available at this time.

Past Events

Jun 18, 2024 8:00 AM EDT

Zentalis Pharmaceuticals Investor Call

Click Here for Webcast

Supporting Materials

Investor Call Deck 343.8 KB

May 28, 2024 10:30 AM EDT

TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA

Click Here for Webcast

Mar 11, 2024 3:20 PM EDT

Leerink Partners Global Biopharma Conference 2024

Click Here for Webcast

Science Center

10275 Science Center Drive
Suite 200
San Diego, CA 92121

About Us

Our Company Management Team Board of Directors Scientific Advisory Board Partners & Collaborations Contact

Our Pipeline

Overview Azenosertib ZN-d5 BCL-xL Degrader Clinical Trials

Our Approach

Integrated Discovery Engine Supporting Publications

Investors & Media

News & Events Stock Information Financials & Filings Corporate Governance Investor Resources

Privacy Policy

Terms of Use

Expanded Access Policy

Site Map

Careers